Literature DB >> 31371327

Cortical blindness due to cerebral infarct in advanced pancreatic cancer.

Nivedita Nimesh1, Sanjeev Kumar Verma2, Sanjiv Kumar Gupta1.   

Abstract

A 65-year-old man, a known case of advanced pancreatic cancer on cisplatin and gemcitabine-based chemotherapy, presented with sudden bilateral painless loss of vision with altered sensorium. Clinical examination showed a normal pupillary light reaction, normal anterior segment and normal fundus. MRI brain showed bilateral parieto-occipital infarct. This report highlights the incidence of cortical blindness due to thromboembolism at the cerebral level in pancreatic cancer. Cerebral ischaemic events occur at an advanced stage of pancreatic cancer already diagnosed at stroke onset and portend a poor prognosis. Anticoagulation therapy, especially low molecular weight heparin, remains the best strategy to prevent recurrences. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  pancreatic cancer; stroke; venous thromboembolism; visual pathway

Mesh:

Year:  2019        PMID: 31371327      PMCID: PMC6677957          DOI: 10.1136/bcr-2017-223843

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Stroke as the first manifestation of concealed cancer.

Authors:  Hyung-Min Kwon; Bong Su Kang; Byung-Woo Yoon
Journal:  J Neurol Sci       Date:  2007-04-03       Impact factor: 3.181

2.  High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.

Authors:  Russell A Moore; Nelly Adel; Elyn Riedel; Manisha Bhutani; Darren R Feldman; Nour Elise Tabbara; Gerald Soff; Rekha Parameswaran; Hani Hassoun
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

3.  Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients.

Authors:  Shau-Hsuan Li; Wei-Hsi Chen; Yeh Tang; Kun-Ming Rau; Yeng-Yang Chen; Tai-Lin Huang; Jia-Shou Liu; Cheng-Hua Huang
Journal:  Clin Neurol Neurosurg       Date:  2005-04-25       Impact factor: 1.876

Review 4.  Pancreatic cancer and thromboembolic disease.

Authors:  Alok A Khorana; Robert L Fine
Journal:  Lancet Oncol       Date:  2004-11       Impact factor: 41.316

Review 5.  Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.

Authors:  Janusz Rak; Joanne L Yu; James Luyendyk; Nigel Mackman
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

6.  Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity.

Authors:  So Yeon Oh; Jee Hyun Kim; Keun-Wook Lee; Soo-Mee Bang; Jin-Hyeok Hwang; Doyeun Oh; Jong Seok Lee
Journal:  Thromb Res       Date:  2008-01-30       Impact factor: 3.944

7.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 8.  Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.

Authors:  David Ansari; Daniel Ansari; Roland Andersson; Åke Andrén-Sandberg
Journal:  Hepatobiliary Surg Nutr       Date:  2015-10       Impact factor: 7.293

9.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors:  Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal:  Lancet Oncol       Date:  2009-08-31       Impact factor: 41.316

Review 10.  Cerebral ischemic events in patients with pancreatic cancer: A retrospective cohort study of 17 patients and a literature review.

Authors:  Mathieu Bonnerot; Lisa Humbertjean; Gioia Mione; Jean-Christophe Lacour; Anne-Laure Derelle; Jean-Charles Sanchez; Nolwenn Riou-Comte; Sébastien Richard
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.